C. Grabrucker

发表

Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.

H. Salih, A. Kremser, H. Kolb, 2011, Immunotherapy.

Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.

A. Borkhardt, A. Kremser, H. Kolb, 2021, Immunobiology.

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease

A. Borkhardt, A. Kremser, H. Kolb, 2019, Immunological investigations.

Dendritic Cells (DCs) Can Be Successfully Generated From Leukemic Blasts in Individual Patients With AML or MDS: An Evaluation of Different Methods

H. Salih, A. Kremser, S. Kufner, 2010, Journal of immunotherapy.

Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients’ Response to Immunotherapy

A. Borkhardt, A. Kremser, H. Kolb, 2015, Cell communication & adhesion.

In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping

Arndt Borkhardt, R. Buhmann, A. Borkhardt, 2013, Clinical and Experimental Medicine.

Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.

R. Reibke, A. Kremser, H. Kolb, 2010, Cellular immunology.

Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.

R. Buhmann, P. Lichtner, A. Borkhardt, 2008, Cancer genomics & proteomics.

The Quality and Quantity of Leukemia-derived Dendritic Cells From Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Are a Predictive Factor for the Lytic Potential of Dendritic Cells-primed Leukemia-Specific T Cells

A. Kremser, H. Kolb, C. Schmid, 2010, Journal of immunotherapy.

The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders

H. Salih, A. Kremser, H. Kolb, 2009, Leukemia & lymphoma.

Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.

H. Salih, A. Kremser, H. Kolb, 2011, Immunotherapy.

The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders

H. Salih, A. Kremser, H. Kolb, 2009, Leukemia & lymphoma.